Seguir
Silvestre Massimo Modestia
Silvestre Massimo Modestia
Email confirmado em usp.br
Título
Citado por
Citado por
Ano
Biased agonist TRV027 determinants in AT1R by molecular dynamics simulations
SM Modestia, M Malta de Sá, E Auger, GHG Trossini, JE Krieger, ...
Journal of chemical information and modeling 59 (2), 797-808, 2019
142019
Alkylphosphocholines as promising antitumor agents: Exploring the role of structural features on the hemolytic potential
MM de Sa, KFM Pasqualoto, SM Modestia, CO Rangel‐Yagui
Molecular Informatics 33 (1), 53-64, 2014
52014
Integrated systems biology approach identifies gene targets for endothelial dysfunction
I Pinheiro‐de‐Sousa, MH Fonseca‐Alaniz, G Giudice, IC Valadão, ...
Molecular Systems Biology 19 (12), e11462, 2023
2023
In silico network-based screening reveals candidates for endothelial dysfunction therapy
I Pinheiro-de-Sousa, G Giudice, MH Fonseca-Alaniz, SM Modestia, ...
bioRxiv, 2022.11. 17.516953, 2022
2022
Planejamento e desenvolvimento de ligantes não peptídicos com atividade agonista enviesada no receptor de angiotensina II tipo 1 empregando-se técnicas de modelagem molecular e …
SM Modestia
Universidade de São Paulo, 2019
2019
Biased agonism in AT1R by molecular dynamics
SM Modestia, JE Krieger, CO Rangel-Yagui
Abstracts, 2017
2017
Non-Equilibrium Molecular Dynamics to Simulate Shear Stress on Angiotensin II Type 1 (AT1) Receptor
MM de Sa, SM Modestia, CO Rangel-Yagui, JE Krieger
Biophysical Journal 110 (3), 325a, 2016
2016
Conformational changes in the angiotensin II type 1 (AT1) receptor under sheer stress
MM Sá, S Modestia, CO Rangel-Yagui, J Krieger
Abstracts of Papers of the American Chemical Society, 2016
2016
In silico study of the binding mode of biased agonists of the angiotensin II type 1 receptor (AT1)
M Malta de Sá, J Gallottini de Magalhães, S Massimo Modestia, ...
The FASEB Journal 29, LB472, 2015
2015
Pharmacophore model for biased agonists of angiotensin II receptor type 1: a molecular modeling study
SM Modestia, MM Sá, GHG Trossini, CO Rangel-Yagui
Brazilian Journal of Pharmaceutical Sciences 50, 11 res. FCF017, 2014
2014
Construção de farmacóforo para o receptor AT1 baseado em agonistas enviesados, um estudo de modelagem molecular.
SM MODESTIA
Universidade de São Paulo, 2014
2014
Estudo Teórico de atividade hemolítica de derivados alquilfosfolipídicos através de métodos de análise exploratória de dados (HCA E PCA)
SM Modestia, MM Sá, CO Rangel-Yagui
Resumos, 2012
2012
Hemolytic activity of a set of alkylphosphocholines applying hierarchical cluster analysis and principal component analysis
MM Sá, SM Modestia, KFM Pasqualoto, CO Rangel-Yagui
Brazilian Journal of Pharmaceutical Sciences 48, 78 res. FCF151, 2012
2012
Exploratory data analysis of alkylphosphocholines as antitumor agents
MM Sa, SM Modestia, KFM Pasqualoto, CD Rangel-Yagui
Abstr Pap Am Chem Soc, p. 1-p. 1, 2012
2012
Molecular modelling study of a set of alkylphosphocholines as anti-cancer agents
MM Sá, SM Modestia, KFM Pasqualoto, CO Rangel-Yagui
Brazilian Journal of Pharmaceutical Sciences 47, 26 res. FCF047, 2011
2011
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–15